Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by upside80on Apr 04, 2018 3:24pm
72 Views
Post# 27831155

RE:RE:KALY Trading

RE:RE:KALY Trading
lakinisjuice1 wrote: What a joke of a post!!!  You serious!!! A crowded MJ play????  What????  Are you freaking serious?  They have a drug with CBD for Graft Versus Host Disease. Not a crowded play whatsoever. Get a life and do some education and move along.   All star cast and drug is moving through Phase 2 to Phase 3 by September.   Horrible!!!  THESE PLAYS!!!  WHAT???  What more could this company possibly do?  Go cut your grass and get out of this stock.  You have absolutely no clue what you are typing about.


That's a lot of puncutation!

What is funny is how a stock can develop a cult like following. You clearly didn't read the whole post. I said IF this breaks .26 it could spell trouble, which means if it bounces off support and moves higher that would be positive, I also said if you have a long term view you should be fine. 

Yes the marijuana, tech and crypto are all crowded trades if they unwind or you see a sector rotation it could get ugly, have you ever been part of something like that, probably not, you sound like a teenager. I do wish the best of luck to eveyone on here, I'm just not a drone. 
Bullboard Posts